| Term 
 
        | What are the causes of HTN? |  | Definition 
 
        | Primary - Essential HTN Secondary - CKD, Coarctation of the aorta |  | 
        |  | 
        
        | Term 
 
        | What are some contributing factors to HTN in CKD? |  | Definition 
 
        | - Sodium and Volume - Increased vasoconstrictor activity - Decreased vasodilator activity - EPO use - PTH and Ca - Structure changes in arteries - Primary HTN - Renovascular Dz - Others...... |  | 
        |  | 
        
        | Term 
 
        | What causes resistant HTN? |  | Definition 
 
        | - Improper measurement of BP - Fluid overload due to non-adherence of fluid restriction or dialysis regimen - Medication-related (sub therapeutic, wrong-med, side effect) - Obesity and excess EtOH intake |  | 
        |  | 
        
        | Term 
 
        | What medications could be held responsible for inducing HTN? |  | Definition 
 
        | - NSAIDS - Corticosteroids - Calcineurin inhibitors - transplant medications (cyclosporin) - Sympathomimetics - ESA's - Oral Contraceptives - Ilicit drugs like cocaine or amphetamines (maybe crystal meth?) - Certain herbal/supplements |  | 
        |  | 
        
        | Term 
 
        | What are the JNC7 Guidelines? |  | Definition 
 
        | - PreHTN, Stage I, Stage II - Goal BP is <140/90 or <130/80 - Treatment 1st line, compelling indications |  | 
        |  | 
        
        | Term 
 
        | What are the compelling indications and corresponding drug classes for JNC7? |  | Definition 
 
        |   
| Compelling Indication  | Preferred 1st Line Agents  |  
|  Heart failure  | THIAZ, BB, ACEI, ARB, ALDO ANT  |  
| Post myocardial infarction  | BB, ACEI, ALDO ANT  |  
| High CVD risk  | THIAZ, BB, ACEI, CCB  |  
| Diabetes  | THIAZ, BB, ACEI, ARB, CCB  |  
| Chronic kidney disease  | ACEI, ARB  |  
| Recurrent stroke prevention  | THIAZ, ACEI  |  |  | 
        |  | 
        
        | Term 
 
        | To quickly review.....what are the BP goals and first line agents in a CKD patient? |  | Definition 
 
        | BP Goal < 130/80mmHg First line:  ACEi or ARB |  | 
        |  | 
        
        | Term 
 
        | In stages 1-5 of CKD, what are the guidelines of treatment as set forth by JNC7? |  | Definition 
 
        |  Goals of Tx:  Dec. BP, Prevent Progression of CKD, Prevent CV events BP Goals - 130/80 mmHg Non-pharmacological interventions First line:  ACEi or ARB if DM or proteinuria plus a diuretic in most |  | 
        |  | 
        
        | Term 
 
        | What are the treatment goals at stage 5D of CKD? |  | Definition 
 
        | BP Goal:  Go as low as you can go before patient becomes hypotensive Dialysis:  PreHD 140/90 Post HD 130/80 Non-Pharmacological:  Fluid management, sodium restriction First line agents:  ACEi/ARBs despite little/no kidney to preserve, still have CV protective effects, cardiac remodeling, regression of LVH |  | 
        |  | 
        
        | Term 
 
        | What is the 2009 approach to CKD HTN? |  | Definition 
 
        |   ¨Stage I HTN  1.Lifestyle  2.Add 1 drug (ACEi, ARB, CCB, Diuretic) 3.Add 2nd drug (ACEi, ARB, BB, CCB, Diuretic) 4.Add 3rd drug (Adherence; Optimize doses) ¨Stage II HTN 1.Lifestyle + 2 Drugs 2.3rd drug, (Adherence, optimize) 3.4th drug (Address EtOH and salt) 4.Look for 2ndary causes  
 For one more additional compelling indication, give a BB, or CCB for angina pectoris |  | 
        |  | 
        
        | Term 
 
        | What is important regarding thiazide diuretics? |  | Definition 
 
        | - Offer CV protection - Used if GFR >30ml/min - May be used to enhance fluid removal with loop diuretics - Dose in the AM - exacerbate gout, hyperglycemia/DM   Loops:  Furosemide, Bumetanide, Torsemide; primarily used for fluid management, high doses usually in later stages of CKD, used as adjunctive agents or in treatment of hyperkalemia |  | 
        |  | 
        
        | Term 
 
        | What are some things to consider in Dialysis? |  | Definition 
 
        | - Removal of drugs - Intradialytic Hypotension - EDW - "Non-dipping" - Timing of medications around dialysis |  | 
        |  | 
        
        | Term 
 
        | What are some considerations in the Dialysis removal of drugs? |  | Definition 
 
        | - Molecular weight/size - Protein binding - VD - Water Solubility - Plasma Clearance - Dialysis membrane - Blood and Dialysate flow rates - Several BP medications can be removed by HD   |  | 
        |  | 
        
        | Term 
 
        | What's the deal with intradialytic hypotension? |  | Definition 
 
        | Non-pharmacological - Adherence with fluid restriction, Sodium/UF profiling, Extended dialysis sessions   Pharmacologic Approaches - Midodrine, Carnitine, Sertaline |  | 
        |  | 
        
        | Term 
 
        | What is non-dipping in Dialysis? |  | Definition 
 
        | Non-dipping - Typically patients will have a lower blood pressure at night.  CKD patients do not do this and it is a major risk for Cardiovascular events. |  | 
        |  | 
        
        | Term 
 
        | How do we time medications around Dialysis? |  | Definition 
 
        | - Evening preferred for most antihypertensives - If hypotensive during HD:  Hold meds prior, more info to come (Dr. Mason in next lecture or so?) - If on Diuretics dose in AM if possible - Very confusing scheduling |  | 
        |  | 
        
        | Term 
 
        | What is special about Transplant patients? |  | Definition 
 
        | - Usually on corticosteroids with Calcineurin inhibitors, will raise BP - Goal BP is 130/80 - KDOQI recommended agents:  CCB, Diuretic, ACEi, ARB, BB - In terms of Graft loss and transplant kidney function, CCB's were best when treating HTN. - More studies are needed - ACE/ARB used in proteinuria - Other agents could be necessary to control BP   |  | 
        |  | 
        
        | Term 
 
        | What are the key points to remember in CKD patients with HTN? |  | Definition 
 
        |   Hypertension…  ¨Is common among those with CKD ¨Increases risk of CV events 
 ¨ACE/ARB Inhibitors are cornerstone therapies for patients with CKD (esp DM / proteinuria) 
 ¨Fluid/Sodium management is imperative in patients with CKD.  
 ¨Methods to improve adherence should be implemented by all clinicians.  |  | 
        |  |